Chargement en cours...

Use of dapagliflozin in patients with advanced diabetic kidney disease

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are effective for overweight diabetic patients through the induction of glucosuria. However, SGLT2 inhibitors are not recommended for patients with advanced chronic kidney disease (CKD) because they may aggravate renal function and thus become less e...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Kidney Res Clin Pract
Auteurs principaux: Park, Hyun Sun, Jung, Youn Joo, Lee, Dong-Young, Moon, Kyoung Hyoub, Kim, Beom, Kim, Hae Won
Format: Artigo
Langue:Inglês
Publié: Korean Society of Nephrology 2018
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6147181/
https://ncbi.nlm.nih.gov/pubmed/30254854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23876/j.krcp.2018.37.3.292
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!